Publication of a Prospectus
May 05, 2016 10:01 ET
|
AstraZeneca PLC
Publication of Prospectus
Following a routine technical update of the Company's Euro Medium Term Note
("EMTN") programme established in 2007, the following prospectus has been
approved by the UK...
ASTRAZENECA COMPLETES DIVESTMENT OF IMDUR TO CHINA MEDICAL SYSTEM HOLDINGS
May 03, 2016 02:01 ET
|
AstraZeneca PLC
AstraZeneca today announced that it has completed the divestment of the global
rights to Imdur, outside the US, to China Medical System Holdings Ltd and its
associated company, Tibet Rhodiola...
AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY
May 03, 2016 02:00 ET
|
AstraZeneca PLC
ASTRAZENECA COMPLETES ACQUISITION
OF TAKEDA'S RESPIRATORY BUSINESS
AstraZeneca today announced that it has completed the acquisition of the core
respiratory business of Takeda Pharmaceutical Company...
Result of AGM
April 29, 2016 12:30 ET
|
AstraZeneca PLC
ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2016
Results of Annual General Meeting held on 29 April 2016
AstraZeneca PLC announced the results of the voting at its Annual General
Meeting today. As...
POSITIVE CHMP OPINION FOR CAZ AVI
April 29, 2016 07:56 ET
|
AstraZeneca PLC
POSITIVE CHMP OPINION FOR CAZ AVI IN THE EU FOR SERIOUS BACTERIAL INFECTIONS
AstraZeneca today announced that the Committee for Medicinal Products for Human
Use (CHMP) of the European Medicines...
AstraZeneca PLC Announces Q1 2016 Results
April 29, 2016 02:00 ET
|
AstraZeneca PLC
29 April 2016
Financial Summary
+-------------------+-----+----+------+
| | $m | % change |
+-------------------+-----+----+------+
| | ...
Notice of Results
April 28, 2016 04:00 ET
|
AstraZeneca PLC
AstraZeneca First Quarter Results 2016
Tomorrow, Friday, 29 April 2016, AstraZeneca will release first quarter results
for 2016 at 07:00 bst.
An analyst presentation of the first quarter results...
AZ enters US licensing agreement with Ironwood
April 26, 2016 05:19 ET
|
AstraZeneca PLC
ASTRAZENECA ENTERS INTO US LICENSING AGREEMENT WITH IRONWOOD PHARMACEUTICALS FOR
LESINURAD
Agreement includes US rights to Zurampic and lesinurad/allopurinol fixed-dose
combination in...
AstraZeneca PLC Announces Bevespi Aerosphere(TM) Approved by the US FDA for Patients With COPD
April 26, 2016 02:01 ET
|
AstraZeneca PLC
Demonstrated superior improvement in lung function versus mono-components and
placebo
Only long-acting dual bronchodilator delivered through a pressurised metered
-dose inhaler (pMDI) and first...
AZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL
April 08, 2016 02:00 ET
|
AstraZeneca PLC
AstraZeneca AND ELI LILLY AND COMPANY Announce Continuation of Pivotal Clinical
Trial for People with Early Alzheimer's Disease
Phase II/III trial of AZD3293, an oral potent small molecule BACE...